Evidence map›Paper›PMID 30795820›Full record

ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2019

Seroconversion of 1-year-old Mice to Murine Norovirus.

Julia Zaias, Catia Farrington, Robert S Livingston, Linda W Waterman

Abstract read
In one paragraph

Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Preventing the Transmission of Murine Norovirus to Mice (Journal of the American Association for Laboratory Animal Science : JAALAS · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Julia ZaiasVeterinary Resources, University of Miami, Miami, Florida, USA; Comparative Pathology, Department of Pathology and Laboratory Medicine, University of Miami, Miami, Florida, USA. Jzaias@med.miami.edu.
Catia FarringtonNational Institute on Aging, NIH, Bethesda, Maryland, USA.
Robert S LivingstonMolecular Diagnostics, IDEXX BioResearch, Columbia, Missouri, USA.
Linda W WatermanThe Jackson Laboratory, Bar Harbor, Maine, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rodent sentinel screening for adventitious pathogens is an integral part of many biomedical research institutes and universities that use rodents in research. Typical screening programs involving live sentinel animals typically purchase young SPF sentinel animals that are sampled and replaced quarterly. Previous reports suggest that mice as old as 6 mo are effective sentinels for various agents. In efforts to reduce the number of animals used in our sentinel program, we wanted to investigate the possibility of keeping sentinel animals inhouse for 12 mo at a time. We exposed mice (age, 40 to 48 wk) to murine norovirus (MNV) to test whether they could reliably produce detectable levels of antibodies (similar to younger mice) to this adventitious pathogen. Mice first exposed to MNV at 40 to 48 wk of age seroconverted to MNV after both direct inoculation (through gavage) and indirect exposure (from soiled-bedding transfer) at the same or greater frequency than mice first exposed at 8 to 12 wk of age. These findings indicate that, at least for MNV, sentinel residence time can be extended from 3 to 12 mo without compromising the reliability of seroconversion, thus ultimately reducing sentinel animal numbers. This practice, combined with nonanimal testing modalities (for example, exhaust duct sampling), can increase the sensitivity and specificity of rodent surveillance programs and minimize the use of live animals.

Indexed as

AnimalsAntibodies, ViralBedding and LinensCaliciviridae InfectionsFemaleHousing, AnimalLaboratory Animal ScienceMiceNorovirusReproducibility of ResultsRodent DiseasesSentinel SpeciesSeroconversionSpecific Pathogen-Free OrganismsAntibodies, Viral

Identifiers

PMID30795820
PMCPMC6433360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.